These draft recommendations are based on in-depth research, conducted over a 12-month period, into remote decentralised clinical trial methods. They apply to all aspects of RDCTs from design, planning and set-up to close-out and reporting.
3 Key Recommendations
- Answer an important research question
- Keep the focus on participants
- Simplify the participant experience whilst maintaining quality and scientific rigour
Full recommendations will be published at the end of the IMI Trials@Home project in 2024.